SCHEMBL29358277

SCHEMBL29358277

NC(=O)c1ccc(CO)nc1-c1ccc(Cc2ccc(F)c(Cl)c2)cn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 6/20 0.43
CASP1 P29466 1/20 0.38
GRM2 Q14416 2/20 0.37
PIK3CA P42336 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
RPS6KB1 P23443 4/20 0.35
AKT1 P31749 2/20 0.35
HTR1A P08908 1/20 0.35
TGFBR1 P36897 1/20 0.34
TGFBR2 P37173 1/20 0.34
SCD O00767 1/20 0.33
FYN P06241 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29358160 0.87 GPR52 (0.43) GPR52GRM2CYP11B1CYP11B2RPS6KB1
SCHEMBL29357073 0.87 RPS6KB1 (0.45) GPR52CYP11B1CYP11B2RPS6KB1AKT1
SCHEMBL29358037 0.85 GRM2 (0.47) GRM2CYP11B1CYP11B2RPS6KB1AKT1
SCHEMBL29357035 0.84 RPS6KB1 (0.43) GPR52GRM2CYP11B1CYP11B2RPS6KB1
SCHEMBL29356877 0.76 GPR52 (0.40) GPR52GRM2HDAC3HDAC1HDAC2
SCHEMBL29358907 0.75 RPS6KB1 (0.42) GPR52CYP11B1CYP11B2RPS6KB1AKT1
SCHEMBL29358585 0.75 GPR52 (0.42) GPR52CASP1GRM2PIK3CAHDAC3
SCHEMBL29355483 0.74 GPR52 (0.42) GPR52CASP1GRM2PIK3CAHDAC3
SCHEMBL29355505 0.71 RPS6KB1 (0.43) GPR52GRM2CYP11B1CYP11B2RPS6KB1
SCHEMBL1503063 0.70 GPR52 (0.43) GPR52CASP1PIK3CAHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174273-A Compounds and uses thereof 优曼尼蒂治疗公司 2022-03-11 CN disclosed
EP-3941908-A1 COMPOUNDS AND USES THEREOF Yumanity Therapeutics, Inc. (US) 2022-01-26 EP disclosed